Evidence map›Paper›PMID 11136794›Full record

ArticleJournal of clinical microbiology2001

Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus).

M D Ravyn, C B Kodner, S E Carter, J L Jarnefeld, R C Johnson

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Agents of human anaplasmosis and Lyme disease at Camp Ripley, Minnesota.Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2011
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M D RavynDepartment of Microbiology, University of Minnesota Academic Health Center, Minneapolis, Minnesota 55455, USA.
C B Kodner
S E Carter
J L Jarnefeld
R C Johnson

Funding

HUMAN GRANULOCYTIC EHRLICHIOSIS: NORTH CENTRAL U.S.R01AI047896 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JOHNSON, RUSSELL C · 2001 to 2005
$1.8M
PATHOGENESIS OF HUMAN GRANULOCYTIC EHRLICHIOSISR01AI040952 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MUNDERLOH, ULRIKE GERTRUD · 1997 to 2001
$925k
NIAID NIH HHS AI40952NIAID NIH HHS AI47896NIAID NIH HHS R01 AI047896
6 · The paper itself

Abstract

We examined white-footed mice (Peromyscus leucopus) from Minnesota for infection with the etiologic agent of human granulocytic ehrlichiosis (HGE). From April to September 1997, we collected P. leucopus from Washington County, Minnesota, an area enzootic for HGE. Blood was cultivated in HL60 cells for isolation of the HGE agent. Of 59 mice examined, only a single mouse was culture positive for the HGE agent. The 16S ribosomal DNA sequence of the isolate was determined to be identical to that of the HGE agent. The isolate was reactive with monoclonal antibodies to the 44-kDa antigen of the HGE agent and was infectious for laboratory mice.

Indexed as

AnimalsAntigens, BacterialBacterial ProteinsBloodCulture MediaDNA, BacterialDNA, RibosomalEhrlichiaEhrlichiosisGranulocytesHL-60 CellsHumansMiceMice, Inbred BALB CMice, Inbred C3HMice, Inbred DBAAntigens, BacterialBacterial ProteinsCulture MediaDNA, BacterialDNA, RibosomalRNA, Ribosomal, 16S

Identifiers

PMID11136794
PMCPMC87725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.